loadpatents
name:-0.0059878826141357
name:-0.039367914199829
name:-0.00058293342590332
Sauer; Gerhard Patent Filings

Sauer; Gerhard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sauer; Gerhard.The latest application filed is for "electrolysis cell electrolyte pumping system".

Company Profile
0.27.5
  • Sauer; Gerhard - Kassel DE
  • Sauer, Gerhard - Berlin DE
  • Sauer, Gerhard - Heidelberg DE
  • Sauer; Gerhard - Bruchsal DE
  • Sauer; Gerhard - Kelkheim DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Electrolysis Cell Electrolyte Pumping System
App 20080257740 - Helmke; Joachim ;   et al.
2008-10-23
18-nor steroids as selectively active estrogens
App 20050282791 - Hillisch, Alexander ;   et al.
2005-12-22
18 Norsteroids as selectively active estrogens
Grant 6,958,327 - Hillisch , et al. October 25, 2
2005-10-25
11.beta. LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11.beta. LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS
Grant 6,790,842 - Bohlmann , et al. September 14, 2
2004-09-14
11.beta.-HALOGEN-7.alpha.-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11.beta.-HALOGEN-7.alpha.-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS
Grant 6,780,855 - Bohlmann , et al. August 24, 2
2004-08-24
New7.alpha., 17.alpha.-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases
Grant 6,767,903 - Cleve , et al. July 27, 2
2004-07-27
11beta-halogen-7alpha-substituted Estratrienes, Metod For Producing Pharmaceutical Preparations Containing Said 11beta-halogen-7alpha- Substituted Estratrienes And Use Of The Same For Producing Medicaments
App 20030069434 - BOHLMANN, ROLF ;   et al.
2003-04-10
New guanidine derivatives, processes for preparing them and their use as pharmaceutical compositions
App 20010025055 - Amtmann, Eberhard ;   et al.
2001-09-27
Guanidine derivatives, processes for preparing them and their use as pharmaceutical compositions
App 20010023251 - Amtmann, Eberhard ;   et al.
2001-09-20
7 .alpha.-(5-methylaminopentyl)-estratrienes, process for their production, pharmaceutical preparations that contain these 7 .alpha.(5-methylaminopentyl)-estratrienes as well as their use for the production of pharmaceutical agents
Grant 6,288,051 - Bittler , et al. September 11, 2
2001-09-11
7.alpha.-(xi-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7.alpha.-(xi-aminoalkyl-estratrienes as well as their use for the production of pharmaceutical agents
Grant 6,271,403 - Bohlmann , et al. August 7, 2
2001-08-07
7.alpha.-(.xi.-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7.alpha.-(.xi.-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agents
Grant 5,866,560 - Bohlmann , et al. February 2, 1
1999-02-02
N-(8.alpha.-ergolinyl)-amides
Grant 5,547,958 - Sauer , et al. August 20, 1
1996-08-20
2, 13-disubstituted ergolines, their production and use in pharmaceutical agents
Grant 5,411,966 - Sauer , et al. May 2, 1
1995-05-02
2,14-disubstituted ergolines, their production and use in pharmaceutical compositions
Grant 5,401,748 - Sauer , et al. March 28, 1
1995-03-28
8.alpha.-acylamino ergolines and use as pharmaceutical agents
Grant 5,212,178 - Sauer , et al. May 18, 1
1993-05-18
2-substituted ergolines
Grant 5,158,957 - Brumby , et al. * October 27, 1
1992-10-27
Process for the preparation of 2-bromo-8-ergolinyl compounds
Grant 4,970,314 - Borner , et al. November 13, 1
1990-11-13
Process for producing a tangled fibre material from glass fibres and polymer for the production of glass fibre-reinforced plastic mouldings and apparatus for performing the process
Grant 4,886,701 - Ehnert , et al. December 12, 1
1989-12-12
1,2-disubstituted ergolines useful for producing central antidopanminergic or .alpha.2-receptor-blocking activity
Grant 4,874,768 - Huth , et al. October 17, 1
1989-10-17
12- and 13-substituted ergoline derivatives having alpha.sub.2 -receptor-blocking effect
Grant 4,863,929 - Sauer , et al. * September 5, 1
1989-09-05
Antiviral and antitumor xanthate pharmaceutical compositions
Grant 4,851,435 - Sauer , et al. July 25, 1
1989-07-25
2-substituted ergolines having neuroleptic and antidepressant activities
Grant 4,847,262 - Sauer , et al. July 11, 1
1989-07-11
1-alkyl ergolinylthiourea derivatives and their use as antidepressant agents
Grant 4,772,610 - Biere , et al. September 20, 1
1988-09-20
Optionally 11- to 13-substituted ergoline compounds useful as medicinal agents
Grant 4,766,128 - Sauer , et al. August 23, 1
1988-08-23
Process for the preparation of ergoline derivatives
Grant 4,748,248 - Sauer , et al. May 31, 1
1988-05-31
2-substituted ergolines useful as neuroleptics and antidepressants
Grant 4,731,367 - Sauer , et al. March 15, 1
1988-03-15
Process for the simultaneous desizing and bleaching of textile material made from cellulose fibers
Grant 4,539,007 - Rosch , et al. September 3, 1
1985-09-03
11.beta.-aryl estradienes, processes for their production and pharmaceutical preparations containing them
Grant 4,536,401 - Neef , et al. August 20, 1
1985-08-20
(Erolinyl)-N,N-diethylurea derivatives, and their preparation and use
Grant 4,379,790 - Horowski , et al. April 12, 1
1983-04-12
Bicycloalkane derivatives
Grant 4,072,716 - Sauer , et al. February 7, 1
1978-02-07
Process for the preparation of 17.beta.-oxalyl steroids
Grant 3,960,842 - Haffer , et al. June 1, 1
1976-06-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed